| CPC A61K 47/6923 (2017.08) [A61K 9/0053 (2013.01); A61K 38/28 (2013.01); A61K 47/60 (2017.08)] | 17 Claims |
|
1. A method of delivering insulin, comprising:
orally administering to a subject a composition comprising,
a ferrisilicate material having one or more pores, the one or more pores having an average pore size of from 2 nm to 5 nm;
polyethylene glycol; and
insulin;
wherein the insulin at least partially penetrates the pores of the ferrisilicate material to form a ferrisilicate insulin composite,
wherein the polyethylene glycol, at least partially enfolds the ferrisilicate insulin composite, and
wherein the composition has a cumulative insulin release of about 40% after 500 hours following oral administration.
|